OLF1R Olaines Kimiski - Farmaceitiska Rupnica

Council of JSC Olainfarm: JSC Olainfarm Board Members have made gross violations of authority; changes made in the Board

Council of JSC Olainfarm: JSC Olainfarm Board Members have made gross violations of authority; changes made in the Board

Today, on April 4th, JSC Olainfarm Council held a meeting, in which, after hearing members of the Board and finding out gross violations of authority and failure to perform their duties, it made a decision to make changes in the Board, by recalling the current Chairman of the Board of JSC Olainfarm Oļegs Grigorjevs and Members of the Board Mihails Raizbergs and Vladimirs Krušinskis.

To ensure the continuity of the company's operations, the Council of JSC Olainfarm decided on urgent changes in the Board. Lauris Macijevskis has been appointed as the Chairman of the Board; Mārtiņš Pūriņš, Signe Baldere - Sildedze and Milana Beļeviča have been appointed as the Members of the Board. Veranika Dubickaya, Mārtiņš Tambaks, and Raimonds Terentjevs will continue their duties in the Board. In the near future, the Board of JSC Olainfarm will be strengthened with business management and pharmaceutical professionals.

JSC Olainfarm Council was forced to take such a decision on changes in the Board, by acquainting with the situation in the company and discovering serious misconduct by the Board. Misleading news about the composition of the shareholders of JSC Olainfarm was recognized, as well as unlawful announcements about the cancellation of the previously announced extraordinary shareholders meeting. It turned out that on April 1st the Board of JSC Olainfarm had signed and submitted applications to the Register of Enterprises of the Republic of Latvia about non-existent and fictitious extraordinary shareholders meeting.

JSC Olainfarm Council has required the Board to turn to law enforcement authorities to verify if the actions of the mentioned Board Members are unlawful.

About JSC Olainfarm newly appointed Board

The newly appointed Board members have previous experience in the leading management positions.

Lauris Macijevskis is a finance expert who has worked for 16 years in the Latvian banking sector and leading local banks. For the previous three years, Lauris Macijevskis has been performing as the vice president and member of the Board of Directors of JSC DNB banka. Mārtiņš Pūriņš is an IT professional who has previously worked for JSC Sadales tīkls and University of Latvia. Signe Baldere - Sildedze and Milana Beleviča have previously held positions in the Board of JSC Olainfarm. Signe Baldere - Sildedze has acquired education in Switzerland in tourism and hospitality and has been managing a tourism and hospitality related company in Switzerland. Milana Beļeviča has more than 20 years of lawyer experience combining academic and practical knowledge in financial and tax law. She has obtained Degree in law from the University of Latvia; Master's degree in social sciences from the Faculty of Business, Management and Economics at the University of Latvia, as well as a doctoral program in the Law Faculty of Riga Stradins University.

Additional information:

Dana Hasana



Ph.+371  26355895

Laima Auza



Ph. +371  26148001

EN
04/04/2019

Underlying

Reports on Olaines Kimiski - Farmaceitiska Rupnica

 PRESS RELEASE

Delisting of AS "Olainfarm” shares from the Baltic Main list

Delisting of AS "Olainfarm” shares from the Baltic Main list Delisting of AS "Olainfarm” shares from the Baltic Main list With this AS "Olainfarm” informs, that Nasdaq Riga decided on January 7, 2022 to approve the application of AS "Olainfarm” and to delist its shares (ISIN LV0000100501, Ticker OLF1R) from the Baltic Main List. The last listing day of AS "Olainfarm” is set to January 10, 2022. Additional information:  Jānis LeimanisJSC Olainfarm Member of the Management BoardTel. E-pasts:

 PRESS RELEASE

AS "Olainfarm” akcijas izslēdz no Baltijas Oficiālā saraksta

AS "Olainfarm” akcijas izslēdz no Baltijas Oficiālā saraksta AS "Olainfarm” akcijas izslēdz no Baltijas Oficiālā saraksta Ar šo AS "Olainfarm” informē, ka Nasdaq Riga š.g. 7. janvārī pieņēma lēmumu apstiprināt AS "Olainfarm” akciju (ISIN LV0000100501, Biržas kods OLF1R) izslēgšanu no Baltijas Oficiālā saraksta, par pēdējo akciju kotācijas dienu nosakot 2022. gada 10. janvāri. Papildu informācija:Jānis LeimanisAS “Olainfarm” valdes loceklisTel. E-pasts:

 PRESS RELEASE

Notification about results of final buy-back of shares

Notification about results of final buy-back of shares Notification about results of final buy-back of shares Target company Joint Stock Company " Olainfarm ", registration number  40003007246, legal address: Rupnicu str. 5, Olaine, LV-2114, Latvia, phone: (+371) 67013705, e-mail:  , website: , hereinafter - Target Company.  Offeror AS “AB CITY”, registration number 40203174414, date and place of registration 11.10.2018., Rīga, legal address: Ganību dambis 24D, Riga, LV-1005, e-mail:  , website: , hereinafter - Offeror. Number of shares offered for sale A total of 549 8...

 PRESS RELEASE

Paziņojums par galīgās akciju atpirkšanas rezultātiem

Paziņojums par galīgās akciju atpirkšanas rezultātiem Paziņojums par galīgās akciju atpirkšanas rezultātiem Mērķa sabiedrība Akciju sabiedrība „Olainfarm”, reģistrācijas numurs 40003007246, juridiskā adrese: Rūpnīcu iela 5, Olaine, Olaines novads, LV-2114, tālr. (+371) 67013705; e-pasts: , mājaslapas adrese: , turpmāk – Mērķa sabiedrība. Piedāvātājs AS “AB CITY”, reģistrācijas numurs 40203174414, reģistrācijas datums un vieta 11.10.2018., Rīga, juridiskā adrese: Ganību dambis 24D, Rīga, LV-1005, e-pasts: , mājaslapas adrese: , turpmāk - Piedāvātājs. Pārdošanai p...

 PRESS RELEASE

Notification about final share buy-back

Notification about final share buy-back Joint stock company “Olainfarm”, hereinafter referred to as - “the Company”, hereby informs that by decision No. 185 of 28th December 2021, the Financial and Capital Market Commission allowed AS “AB CITY”, registration number 40203174414, to carry out the Company’s  final share buy-back. Final buy-back price is 9,26 EUR per share. The value of one share has been calculated in accordance with Section 74, Paragraphs one, Clause 3 of the Financial Instruments Market Law. The entry date is the next working day after the date of publishing the informati...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch